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Abstract. We assessed interferon-gamma (IFN-g) responses via enzyme-linked immunosorbent spot (ELISPOT) to a
number of S. Typhi antigens in samples from humans with S. Typhi bacteremia and typhoid fever in Bangladesh.
Compared with responses in healthy endemic zone controls, there were significantly increased IFN-g responses at the
time of clinical presentation (acute phase) and at convalescence 14–28 days later. The majority (80–90%) of IFN-g
expressing T cells were CD4+. We observed a significant increase in interleukin-17 (IL-17) positive CD4 + T cells
at convalescent versus acute stage of infection using an intracellular cytokine staining assay. We also found that stimu-
lated peripheral blood mononuclear cells (PBMCs) produced significantly increased levels of a number of cytokines
at the convalescent versus acute phase of infection, including IFN-g, MIP-1b, sCD40L, TNF-b, IL-13, and IL-9. These
results suggest that S. Typhi antigens induce a predominantly Th1 response, but that elevations in other cytokines may
be modulatory.
INTRODUCTION
Typhoid fever is a systemic illness caused by infection with
Salmonella enterica serotype Typhi, a Gram-negative intracel-
lular bacterium. Worldwide, typhoid fever affects an estimated
21 million people each year, causing over 200,000 deaths, with
the highest incidence in South Central and Southeast Asia.
1
Salmonella Typhi is a human-restricted pathogen, a reality
that has complicated advancing our understanding of host–
pathogen interactions. Specifically, data on human immune
responses during wild-type typhoid fever in humans are sparse,
especially data on cellular responses that may be critical in
controlling and clearing S. Typhi infection.
Volunteer challenge studies of wild-type S. Typhi infec-
tion performed in the 1960s and 1970s suggested a key role
for cellular immune responses; however, these studies were
performed before the availability of modern immunologic
techniques.
2 Our current understanding of cellular responses
during S. Typhi infection are extrapolated from murine
models of S. Typhimurium infection (that cause a systemic
typhoidal-like illness in mice), and from human studies with
attenuated S. Typhi live vaccine strains.
3 From murine studies
with S. Typhimurium, it has been shown that interferon-
gamma (IFN-g) produced by Th1 cells plays an important
role in bacterial killing, and depletion of Th1-associated cyto-
kines (i.e., IFN-g, interleukin-12 [IL-12], or tumor necrosis
factor a [TNF-a]) reduces the protective immune response
conferred by attenuated live Salmonella vaccines.
4 In healthy
North American volunteers, oral ingestion of live attenuated
S. Typhi strains has been shown to elicit CD4 and CD8 T cell
responses, with induction of Th1 cytokine responses includ-
ing IFN-g and TNF-a to S. Typhi antigens.
5,6
We have previously shown in patients with wild-type
typhoid fever in Bangladesh that lymphocytes stimulated
with S. Typhi antigens produce strong IFN-g CD4 responses.
7
Here, we report a further assessment of the cellular and
cytokine responses in patients with typhoid fever after stimu-
lation with a number of S. Typhi antigens, including those
identified by a high-throughput screen to identify proteins
that generate an immune response.
8
MATERIALS AND METHODS
Study participants. We enrolled individuals (2–17 years of
age) who presented to either the Kamalapur field station
or Dhaka hospital of the International Centre for Diarrheal
Disease Research, Bangladesh (icddr,b) in Dhaka. The
Kamalapur field site is a clinic located in an urban commu-
nity mostly consisting of urban slums. We collected venous
blood from patients presenting with 3–5 days of fever for
whom there was clinical suspicion of enteric fever by study
clinic staff. Clinical features of study participants are listed
in Table 1; we collected venous blood in tryptic soy broth
(TSB) blood culture bottles and incubated these in a BacT/
Alert automated system (bioMerieux, New Delhi, India).
Positive cultures were confirmed by S. Typhi antisera agglu-
tination and standard biochemical methods.
9 We confirmed
S. Typhi bacteremia in 10 patients, and obtained additional
samples from those patients at acute (2–3 days later) and
convalescent (14–28 days later) stages of illness. Patients were
treated at the discretion of the attending physician, usually
receiving oral cefixime or parenteral ceftriaxone. All patients
recovered. We also obtained blood samples from 10 healthy
Bangladeshi volunteers as endemic zone healthy controls. This
study was approved by the Ethical Research Committee of the
icddr,b and the Institutional Review Board of the Massa-
chusetts General Hospital. Informed consent was obtained
from all adult participants and from parents or legal guardians
of minors.
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1024Isolation of peripheral blood mononuclear cells (PBMCs).
We separated PBMCs from diluted heparinized blood by
Ficoll-Isopaque (Pharmacia, Piscataway, NJ) density gra-
dient centrifugation. We washed isolated PBMCs in phos-
phate buffered saline (PBS, pH 7.2) and resuspended them
in RPMI-1640 media (Gibco, Carlsbad, CA) supplemented
with 10% heat-inactivated fetal bovine serum (FBS) (Hyclone-
Thermo Scientific, Waltham, MA), 100 U/mL penicillin,
100 mg/mL streptomycin, 100 mM pyruvate, and 200 mM
L-glutamine (Gibco).
Proteins used for measuring immune responses. For assess-
ing IFN-g responses by enzyme-linked immunosorbent spot
(ELISPOT), we used the following S. Typhi proteins puri-
fied in 96-well plates using a Biomek FX robotic liquid
handler as previously described
7: flagellar protein (FliC),
chaperone protein EcpD (STY0206, StaB), fimbria-like pro-
tein FimF precursor (STY0595), conserved hypothetical pro-
tein (STY0909), phage shock protein E precursor (STY1375,
PspE), putative secreted hydrolase (STY1522), putative fim-
brial subunit protein (STY2381, StcA), fimbrial subunits
(STY3089 and STY3090, SteEF), and autoinducer 2 import
ATP-binding protein (STY3796, LsrA) (Table 2). We also
extended our analysis of SteE (STY3089) and CsgD (STY1179)
using recombinant antigens prepared as His-fusion pro-
teins expressed from pDEST17 Gateway-based cloning vector
(Invitrogen Life Technologies, Carlsbad, CA) and recovered
by affinity chromatography.
10 We focused our analysis on
these 10 proteins because they (or the operons in which they
are contained) had been previously identified by an immuno-
screen (in vivo-induced antigen technology) using sera from
patients with acute typhoid infection or were related (i.e.,
fimbrial subunit).
8 We also prepared membrane protein (MP)
and lipopolysaccharide (LPS) produced from S. Typhi Ty21a
as target antigens as previously described.
7,11–13 We used
phytohemagglutinin (PHA) as a positive control, and keyhole
limpet hemocyanin (KLH) as a negative control.
IFN-g ELISPOT assay. We assessed IFN-g expression in
acute and convalescent phases of infection using an ELISPOT
assay (MabTec Inc., Cincinnati, OH) in eight patients with
S. Typhi bacteremia, according to manufacturer’s instructions
and as described previously.
7 Briefly, we coated ELISPOT
plates (Multiscreen HTS, Millipore, Billerica, MA) with
100 mL of 15 mg/mL human monoclonal anti-IFN-g antibody
(1-DIK) overnight at 4°C. We washed the plates and blocked
with 10% FBS for 2 hours at room temperature. We added
fresh PBMCs to the wells at a concentration of 2 + 10
5 per
well for each antigen. We added S. Typhi antigen or control
at a concentration of 140 ng/well of total preparation for each
purified antigen, making the final concentration 0.7 mg/mL.
We also added MP to ELISPOT plates at a concentration of
10 mg/mL in 200 mL culture, and PHA (Murex Diagnostics
Ltd., Temple Hill, UK), at a final concentration of 2.5 mg/mL,
as a positive control. We used KLH as a negative control.
We incubated the plates for 20 hours at 37°C in 5% CO2,
washed them, and added anti-IFN-g antibody (7-B6-1-biotin;
1:500 dilution). We incubated the plates for 2 hours at
room temperature, washed them, added streptavidin-HRP
(1:500 dilution), and incubated the plates again for 1 hour
at room temperature. We developed the plates with amino-
ethylcarbazole with H2O2, and then washed and dried
them. We counted the spots under a stereomicroscope, and
expressed results as the number of spots/10
6 PBMCs, sub-
tracting the number of spots in media only wells from spots
in antigen-specific wells. We compared differences between
groups using the Wilcoxon signed-rank test.
Intracellular cytokine staining. We characterized cytokine
production in six patients by intracellular cytokine staining
(ICS), as described previously.
7 Briefly, we resuspended
PBMCs at a concentration of 10
6 cells/mL in RPMI medium
(Gibco) supplemented with 10% fetal calf serum (FCS, Gibco).
We cultured these PBMCs in U-bottom culture plates in
the presence of S. Typhi Ty21a MP, STY3089, STY1179,
S. TyphiTy21a LPS, phorbol 12-myristate 13-acetate (PMA),
or without stimulation. We added co-stimulatory molecules
anti-CD28 (1.0 mg/mL; clone 28.2; BD Pharmingen, San Jose,
CA) and anti-CD49d (1.0 mg/mL; clone 9F10; BD Pharmingen)
to the culture and incubated at 37°C with 5% CO2. After
2 hours of incubation, we added brefeldin A (Sigma, St. Louis,
MO) at a concentration of 10 mg/mL and incubated for
another 4 hours. We washed the cells with PBS and 2% FCS.
We then stained cells for 30 min at 4°C with cell surface
antibodies anti-CD3-PE-Cy7, anti-CD4-Amcyan, anti-CD8-PE
Texas red, anti-CD14-APC-Cy7, and anti-CD56-PerCP-Cy5.
We lysed red cells using a FACS lysing solution (BD Biosci-
ence, San Jose, CA) for 10 minutes, and then permeabilized
cells using FACS permeabilizing solution (BD Bioscience) for
10 minutes in a dark room. We washed the permeabilized
cells and incubated them with anti-IL-13-PE, IL-10-APC,
IFN-g-V450, and IL-17a-Alexa Fluor488 (BD Bioscience)
Table 1
Clinical features of study participants with bacteremia-confirmed
typhoid fever in this study
Features Value/characteristics
Sample size (N) 10
Median age in years
(25th and 75th percentile)
3.3 (2.5–4.5)
Gender (male) 5
Median maximum temp
(25th and 75th percentile)
39.5°C (39.1–39.8°C)
Duration of fever in days (median)
(25th and 75th percentile)
5 (4–5)
Abdominal pain (N)1
Constipation (N)0
Coated tongue (N)0
Diarrhea (N)3
Vomiting (N)0
Table 2
Salmonella Typhi proteins used in this study
STY no. Annotated name Protein
Flagellar protein FliC
STY0206 Chaperone protein EcpD StaB
STY0595 Fimbria like protein FimF precursor FimF
STY0909 Uncharacterized protein
STY1375 Phage shock protein E PspE
STY1522 Putative secreted hydrolase
STY2381 Putative fimbrial subunit protein StcA
STY3089 Fimbrial subunit SteE
STY3090 Fimbrial subunit SteF
STY3796 Autoinducer 2 import
ATP-binding protein
LsrA
STY1179 Putative regulatory protein CsgD
Membrane
preparation
Crude membrane preparation
containing at least 934
S. Typhi proteins
MP
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buffer (BD Bioscience), and kept cells at 4°C until flow
cytometry was performed. We focused our analysis on these
4 pro-inflammatory regulatory cytokines as surrogate markers
of Th1 (IFN-g), Th2 (IL-13), Treg (IL-10), and Th17 (IL-17)
responses. We performed flow cytometry with a FACSAriaIII
(BD Bioscience). We identified the lymphocyte population
on forward versus side scatter plot, and then we gated for
CD3+ sub-populations. We used Flow-Jo software for flow
cytometry data analysis (Treestar, Ashland, OR). We sub-
tracted unstimulated responses from the antigen-specific
responses and performed statistical comparison using the
Student’s t-test.
Cytokine assay by Luminex. We cultured PBMCs from
three bacteremic patients with MP antigen and collected
culture supernatant after 48 hours of incubation at 37°C in
5% CO2. We measured concentrations of cytokines using
a Luminex human cytokine/chemokine assay kit (Millipore)
according to manufacturer’s instructions
14; briefly, we filtered
culture supernatant through a nitrocellulose membrane to
remove debris. We prepared standards in Assay Buffer in
10-fold dilutions, and added 25 mL of each standard to a final
volume with media of 50 mL. In sample wells, we added
25 mL of assay buffer and 25 mL of culture supernatant to
make a final volume of 50 mL. We incubated the plates
at room temperature for 1 hour with shaking, and gently
removed fluid by vacuum and washed the wells twice with
wash buffer. We then added 25 mL of detection antibody to
each well, covered the plate with aluminum foil, and incu-
bated it for 1 hour at room temperature. After incubation,
we added 25 mL streptavidin-phycoerythrin to each well, and
incubated the plates for another 30 minutes with shaking.
After washing, we added 150 mL of FACS fluid (BD Bio-
sciences) to each well and analyzed results in Luminex 100 IS
(Bio-Rad, Hercules, CA). We subtracted unstimulated cyto-
kine values (pg/mL) from the stimulated value to calculate net
stimulation, log transformed the data, and compared means
using a paired t-test. We calculated relative change by divid-
ing mean net stimulation at convalescent stage by mean net
stimulation at acute stage.
RESULTS
IFN-g responses by ELISPOT. Using the ELISPOT method,
we found significantly increased IFN-g responses at both
acute and convalescent stages of infection upon stimulation
with all S. Typhi proteins except STY0909, compared with
endemic-zone healthy controls (Figure 1). We did note a sig-
nificant increase in IFN-g response in convalescent compared
with acute samples for STY1522 (a putative secreted hydro-
lase, P = 0.03); and a trend was seen for Phage shock pro-
tein E (STY 1375, P = 0.06) and a putative fimbrial subunit,
StcA (STY2381, P = 0.08). Minimal responses were detected
to our negative control (KLH), and responses to the positive
control (PHA) did not differ significantly between patients
or healthy controls.
CD4 and CD8 responses. Using intracellular staining and
flow cytometry, we found that the majority (60–80%) of cells
producing IFN-g in response to all antigens tested at both
the acute stage and convalescence were CD4+ T cells, with
a smaller number (10–20%) of CD8+ cells (Figure 2). The
IL-17 responses in CD4+ cells to S. Typhi antigens MP and
STY3089 were also detectable at convalescence, but not
during the acute stage of illness (Figure 3). We did not see
any intracellular expression of IL-10 or IL-13 in CD4+ or
CD8+ cells.
Figure 1. Interferon-gamma (IFN-g) enzyme-linked immunosorbent spot (ELISPOT) responses to S. Typhi antigens in peripheral blood
mononuclear cells (PBMCs) from patients with typhoid fever at acute and convalescent phases of illness. KLH = keyhole limpet hemocyanin;
PHA = phytohaemagglutinin; HC = healthy controls; MP = membrane preparation. * indicates statistically significant increase (P < 0.05) at acute
and convalescent phase of illness in typhoid fever patients compared with healthy controls. F indicates statistically significant increase (P < 0.05)
at acute compared with convalescent phase of illness in typhoid fever patients.
1026 BHUIYAN AND OTHERSCytokine responses in culture supernatants. To further char-
acterize the cytokine responses during the acute versus con-
valescent stages of infection, we used the human cytokine/
chemokine premixed multiplex assay (Millipore) to measure
the concentration of 39 cytokines in culture supernatants of
PBMCs stimulated with S. Typhi MP antigen for 48 hours
(Supplemental Table 1). We found significant increases for
the following cytokines expressed from stimulated PBMCs
in convalescent versus acute stages of illness: IFN-g, MIP-1b,
IL-13, sCD40L, Fractalkin, IL-9, TNF-b, Eotaxin, and IL-15
(Table 3).
DISCUSSION
Protective immune responses to S. Typhi infection are com-
plex and involve both humoral and cellular immune
responses.
3,15 Antibodies play a role in host defense against
extracellular Salmonella, and bactericidal activity of serum
increases with age in typhoid-endemic areas.
16 However,
because S. Typhi can persist intracellularly, cell-mediated
immunity is critical to clearance of infection.
3,15 Animal studies
of S. Typhimurium suggest that IFN-g CD4 and CD8 responses
are important mediators in eliminating infection,
17,18 and oral
attenuated Salmonella vaccines (e.g., Ty21a and CVD 908)
that are protective have been shown to stimulate strong cellu-
lar immune responses, including proliferative responses and
secretion of Th1-type cytokines (e.g., IFN-g and TNF-a) after
stimulation with specific S. Typhi antigens.
5,6 However, there
are few data on cell-mediated immune responses in humans
during wild-type S. Typhi infection, especially to purified anti-
gens. We have previously shown that IFN-g responses against
S. Typhi antigens are elevated in both acute and convalescent
stages of human infection compared with healthy controls,
7
and in this report we confirm such findings using additional
antigens previously identified by humoral immunoproteomic
screening. We also show a CD4+ IL-17 response to infection,
and the production of several other cytokines. The increased
IFN-g response seen in this analysis is consistent with other
human studies.
19 A transcriptional analysis of the peripheral
blood of patients with acute typhoid fever also showed
increased expression of genes associated with a response to
IFN-g compared with healthy controls.
20 Using an ELISPOT
assay, we found that the majority of the target antigens,
including FliC and fimbria-associated proteins, induced a
significant increase in IFN-g responses in both acute and
convalescent phases of infection compared with healthy con-
trols. FliC is a bacterial flagellin known to induce an innate
response through its activity on TLR5 or NLRC4, and its
use as a diagnostic marker of acute typhoid fever has been
Figure 2. Characterization of interferon-gamma (IFN-g) producing T cells during stimulation with typhoid antigens, expressed as a percentage
of total CD4 and CD8 cells at acute and convalescent phases of illness. PMA = phorbol myristate acetate; MP = membrane preparation;
LPS = lipopolysaccharide; IFN-g, interferon-gamma.
Figure 3. Interleukin-17 (IL-17) responses in CD4 cells assessed
by intracellular cytokine staining assay following stimulation with
membrane preparation (MP), fimbrial protein (STY3089), CsgD
(STY1179), LPS, phorbol, 12-myristate 13-acetate (PMA), or no anti-
gen (No Ag). * Indicates statistically significant increase (P < 0.05)
from acute to convalescent phase of illness in patients with typhoid
fever and † indicates statistically significant increase at convalescent
phase compared with healthy controls.
Table 3
Cytokines responses (pg/mL) in acute and convalescent (mean ± SE
of mean) samples of typhoid fever patients
Mean acute Mean convalescence Relative change P value
IFNg 572.8 (393) 5482.0 (2941) 9.6 0.0492
MIP-1b 80.0 (54) 2202.6 (557) 27.5 0.0417
IL-13 17.5 (8) 198.8 (97) 11.3 0.0104
sCD40L 6.3 (6) 100.0 (32) 16 0.0354
Fractalkin 4.8 (5) 59.7 (30) 12.5 0.0101
IL-9 1.1 (1) 31.0 (10) 29.6 0.0065
TNF-b 0.82 (0.8) 27.9 (14) 34.2 0.0366
Eotaxin 0.71 (0.7) 5.5 (2) 7.8 0.0154
IL-15 0.42 (0.4) 4.0 (0.8) 9.5 0.0130
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21 When administered as a vaccine antigen in mice,
FliC enhanced subsequent induction of IFN-g CD4 responses
and bacterial clearance in mice subsequently infected with S.
Typhimurium.
22 A number of fimbrial subunits and fimbria-
associated proteins also induced an IFN-g response, including
StaB, SteEF, StcA, and FimF. The staB, steEF, and stcA are
part of putative chaperone-usher-dependent fimbrial operons:
staA-G is encoded within Salmonella pathogenicity island
(SPI) 6 of S. Typhi and is rarely found in other Salmonella
spp.
23; steA-G is found in a number of Salmonella serotypes,
but is not found in S. Typhimuruim
23; stcABCD is found in
both S. Typhi and S. Typhimurium and is thought to contrib-
ute to long-term intestinal carriage in a murine model.
24 The
fimF encodes the adaptor component of a mannose-sensitive
type I fimbria encoded by the fim gene cluster, which is well
conserved among Salmonella serotypes and mediates attach-
ment to epithelial cells.
24,25 Mutations in the fimF gene of S.
Typhimurium result in a nonfimbriate phenotype.
26
The IFN-g responses were also seen to a putative hydrolase
encoded by STY1522, phage shock protein E (pspE), and
ABC transporter, LsrA. The lsrA (STY3796) is the first gene
of the lsr (luxS regulated) operon, which encodes an ABC
transporter for the quorum sensing molecule, autoinducer-2.
27
It has been suggested that quorum sensing may play a role in
the ability of S. Typhimurium to invade epithelial cells through
regulation of SPI-1 and flagellar genes.
28
In S. Typhi-infected humans, our group has previously
shown that the majority of lymphocytes involved in IFN-g
responses to S. Typhi proteins, including MP, PagC, and StaF,
are CD4+ cells. In this study, we extended these observations
to SteE, a fimbrial subunit protein, and CsgD, a major
transcriptional regulator of biofilm formation in the
S. Typhimurium model
29; we also show that ~80% of IFN-g
secretion originates from CD4 cells. As the most prominent
IFN-g responses were observed with MP stimulation, we
proceeded to use MP to stimulate cells for subsequent analy-
sis of cytokine responses.
Lymphocytes of S. Typhi-infected patients in convalescence
stimulated with MP for 48 hours generated significantly
higher IFN-g, MIP-1b, TNF-b, IL-13, and IL-9 responses than
lymphocytes of the same patients in the acute phase of infec-
tion. Some of the highest fold changes were seen predomi-
nantly in IFN-g, MIP-1b, and sCD40L, suggesting that in
patients with typhoid fever, antigen-specific responses are
predominantly Th1 associated. Whether these fold changes
reflect an increase in cytokine expression per activated cell,
or an increase in a population of cells is uncertain because
the assay was based on total PBMCs. A high fold change was
also seen with macrophage inflammatory protein 1-b (MIP1-b),
a protein associated with recruitment of T cells and macro-
phages. In an in vitro and in vivo model of Listeria mono-
cytogenes, MIP-1b (along with MIP-1a, RANTES, and ATAC,
the latter not measured in our analysis) are co-secreted with
IFN-g and acts synergistically to drive a Th1 response.
30 Further-
more, sCD40L stimulation has been shown to play a role in
regulating Th1 responses through increased T cell stimulation
and production of IFN-g.
31 In addition to elevations seen in
Th1-associated cytokines, elevations of the Th2-associated
cytokines, IL-13 and IL-9, were also present suggesting that
these cytokines may act as modulators of the Th1 response.
Interestingly, a number of cytokines associated with neutro-
phil activity were elevated above the level of detection in our
assay (Supplementary Table 1), including GRO and IL-8, at
both the acute and convalescent phases of illness. This obser-
vation may support previous results that found that the early
host transcriptional response to S. Typhi infection was domi-
nated by a neutrophil response
20; one limitation of this
analysis is that as a result of sample volume limitations, we
were unable to evaluate changes in cytokine response serially
over multiple incubation times. Our findings, however, add
to data from previous studies of typhoid patients, which
showed expression of genes associated with IFN-g and Th1-
type responses.
20
Using intracellular staining by flow cytometry, we also
showed that lymphocytes from convalescing typhoid patients
stimulated for 6 hours with MP contained more CD4+ cells
expressing IL-17 compared with patients in the acute stage of
typhoid fever. In an experimental simian immunodeficiency
virus (SIV) infection model, an impairment of the IL-17 axis
results in dissemination of S. Typhimurium.
32 Our findings
also suggest that IL-17 may play a role during systemic
Salmonella infection in humans, and add to prior findings in
mice where the IL-17 response of ileal T lymphocytes was
shown to also play an important role in the early stages of
protection against S. Typhimurium,
33 was induced by IL-6,
and was Nod1- and Nod2-dependent.
34 The lack of IL-17 seen
in the supernatant of a 48-hour culture in our current study
after stimulation may reflect IL-17 expression as an early
cytokine, and that other cytokines such as IFN-g may be
induced later.
33 The absence of changes in intracellular
expression of other cytokines after 6 hours of stimulation, in
contrast with their elevations as soluble forms at 48 hours,
may reflect cascade induction. These observations are limited
by the fact that, because of sample volume limitations, we
were unable to evaluate intracellular cytokines serially at
multiple incubation times.
Our study has a number of limitations, including the
absence of febrile control patients with documented illness
other than S. Typhi, and our inability to perform all analyses
with each antigen in each patient because of a limited quan-
tity of blood and antigens. Our study is also one of character-
ization, and because of its use of freshly harvested human
blood does not include a mechanistic analysis. However,
despite these limitations, our report represents one of the first
descriptions of cellular and cytokine responses in humans
with wild-type typhoid fever in the field. We show that in
patients with typhoid fever, prominent IFN-g responses are
seen in both acute and convalescent phases of infection, the
majority of which involve CD4 cells. We also show a broader
Th1 response and a Th17 response in convalescence, and that
these are accompanied by mild elevations in Th2 cytokines
that may be modulatory. Our results also suggest that anti-
gens used in our analysis may have some use as vaccine tar-
gets because they are recognized by cellular responses in
patients recovering from typhoid fever. Similarly, these anti-
gens may have some use as diagnostic assay targets because
they induce detectable IFN-g responses in patients with
typhoid fever but not in control patients in this typhoid-
endemic area.
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